C-Type Lectin Receptor (CLR)–Fc Fusion Proteins As Tools to Screen for Novel CLR/Bacteria Interactions: An Exemplary Study on Preselected Campylobacter jejuni Isolates
Sabine Mayer,Rebecca Moeller,João T. Monteiro,Kerstin Ellrott,Christine Josenhans,Bernd Lepenies
DOI: https://doi.org/10.3389/fimmu.2018.00213
IF: 7.3
2018-02-13
Frontiers in Immunology
Abstract:C-type lectin receptors (CLRs) are carbohydrate-binding receptors that recognize their ligands often in a Ca<sup>2+</sup>-dependent manner. Upon ligand binding, myeloid CLRs in innate immunity trigger or inhibit a variety of signaling pathways, thus initiating or modulating effector functions such as cytokine production, phagocytosis, and antigen presentation. CLRs bind to various pathogens, including viruses, fungi, parasites, and bacteria. The bacterium <i>Campylobacter jejuni</i> (<i>C. jejuni</i>) is a very frequent Gram-negative zoonotic pathogen of humans, causing severe intestinal symptoms. Interestingly, <i>C. jejuni</i> expresses several glycosylated surface structures, for example, the capsular polysaccharide (CPS), lipooligosaccharide (LOS), and envelope proteins. This "Methods" paper describes applications of CLR-Fc fusion proteins to screen for yet unknown CLR/bacteria interactions using <i>C. jejuni</i> as an example. ELISA-based detection of CLR/bacteria interactions allows a first prescreening that is further confirmed by flow cytometry-based binding analysis and visualized using confocal microscopy. By applying these methods, we identified Dectin-1 as a novel CLR recognizing two selected <i>C. jejuni</i> isolates with different LOS and CPS genotypes. In conclusion, the here-described applications of CLR-Fc fusion proteins represent useful methods to screen for and identify novel CLR/bacteria interactions.
immunology